JessicaRose(Mckay)CastleMD

PubMed

• 96 citations
  A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.
  David C Klonoff, Jing Wang, David Rodbard, Michael A Kohn, Chengdong Li
  Journal of Diabetes Science and Technology. 2023-09-01
• 32 citations
  Prediction of Hypoglycemia During Aerobic Exercise in Adults With Type 1 Diabetes.
  Ravi Reddy, Navid Resalat, Leah M. Wilson, Jessica R. Castle, Joseph El Youssef
  Journal of Diabetes Science and Technology. 2019-01-17
• 10 citations
  Enabling fully automated insulin delivery through meal detection and size estimation using Artificial Intelligence.
  Clara Mosquera-Lopez, Leah M Wilson, Joseph El Youssef, Wade Hilts, Joseph Leitschuh
  NPJ Digital Medicine. 2023-03-13

Journal Articles

• Comparative Pharmacokinetic/Pharmacodynamic Study of Liquid Stable Glucagon vs Lyophilized Glucagon in Type 1 Diabetes Subjects  
  Castle JR, El Youssef J, Branigan D, Newswanger B, Strange P, Cummins M, Shi L, Prestrelski S, J Diabetes Sci Technol, 1/1/2016
• Randomized Trial of a Dual-hormone Artificial Pancreas with Dosing Adjustment During Exercise Compared with No Adjustment and Sensor-augmented Pump Therapy  
  Jacobs P, El Youssef J, Reddy R, Resalat N, Branigan D, Condon J, Preiser N, Ramsey K, Jones M, Edwards C, Kuehl K, Leitschuh J, Rajhbeharrysing U, Castle JR, Diabetes, Obesity and Metabolism, 1/1/2016
• Non-adjunctive Use of Continuous Glucose Monitoring for Diabetes Treatment Decisions  
  Castle JR, Jacobs PG, J Diabetes Sci Technol, 1/1/2016
• Fabrication of a Flexible Amperometric Glucose Sensor Using Additive Processes  
  Du X, Durgan C, Matthews J, Motley JR, Tan X, Pholsena K, Arnadottir L, Castle JR, Jacobs PG, Cargill RS, Ward WK, Conley JF, Herman GS, ECS Journal of Solid State Science and Technology, 1/1/2015
• Factors Affecting the Success of Glucagon Delivered During an Automated Closed-loop System in Type 1 Diabetes  
  Bakhtiani P, El Youssef J, Duell AK, Branigan DL, Jacobs PG, Lasarev MR, Castle JR, Ward WK, Journal of Diabetes and its Complications, 1/1/2015
• Is Glucagon Needed in Type 1 Diabetes?  
  Castle JR, The Lancet Diabetes and Endocrinology, 1/1/2015
• Automated Control of an Adaptive Bi-hormonal, Dual-sensor Artificial Pancreas and Evaluation During Inpatient Studies  
  Jacobs P, El Youssef J, Castle JR, Bakhtiani P, Branigan D, Breen M, Bauer D, Preiser N, Leonard G, Stonex T, Ward WK, IEEE Transactions on Biomedical Engineering, 1/1/2014
• Biochemical Stabilization of Glucagon at Alkaline pH  
  Caputo N, Jackson M, Castle JR, El Youssef J, Bakhtiani P, Bergstrom C, Carroll J, Breen M, Leonard G, David L, Roberts C, Ward WK, Diabetes Technol Ther, 1/1/2014
• Modeling Glucose Sensor Error  
  Facchinetti A, Del Favero S, Sparacino G, Castle JR, Ward WK, Cobelli C, IEEE Transactions on Biomedical Engineering, 1/1/2014
• Can Glucose Be Monitored Accurately at the Site of Subcutaneously Insulin Delivery?  
  Ward WK, Castle JR, Jacobs PG, Cargill RS, J Diabetes Sci Technol, 1/1/2014
• A Review of Artificial Pancreas Technologies with an Emphasis on Bi-hormonal Therapy  
  Bakhtiani PA, Zhao LM, El Youssef J, Castle JR, Ward K, Diabetes Obes Met, 1/1/2013
• Discomfort from an Alkaline Formulation Delivered Subcutaneously in Humans  
  Ward WK, Castle JR, Braigan D, Massoud R, El Youssef J, Clin Drug Investig, 1/1/2012
• Stable Liquid Glucagon Formulations for Rescue Treatment and Bi-hormonal Closed-loop Pancreas  
  Jackson, MA, Caputo N, Castle JR, David, LL, Roberts, CT, Ward WK, Current Diabetes Reports, 1/1/2012
• The Effect of Rising vs Falling Glucose Levels on Amperometric Glucose Sensor Lag and Accuracy in Type 1 Diabetes  
  Ward WK, Engle JM, Branigan D, El Youssef J, Massoud RG, Castle JR, Diabetic Medicine, 1/1/2012
• The Accuracy Benefit of Multiple Amperometric Glucose Sensors in Persons with Type 1 Diabetes  
  Castle JR, Pitts A, Hanavan K, Muhly R, El Youssef J, Hughes-Karvetski C, Kovatchev B, Ward WK, Diabetes Care, 1/1/2012
• A Controlled Study of the Effectiveness of a Highly Adaptive Closed Loop Algorithm to Minimize Corticosteroid-induced Stress Hyperglycemia in Type 1 Diabetes  
  El Youssef J, Castle JR, Branigan D, Massoud RG, Breen ME, Ward WK, J Diabetes Sci Tech, 1/1/2011
• Safe Glycemic Management During Closed-loop Treatment of Type 1 Diabetes: the Role of Glucagon, Use of Multiple Sensors, and Compensation for Stress Hyperglycemia  
  Ward WK, Castle JR, and El Youssef J, J Diabetes Sci Tech, 1/1/2011
• Predictors of Glucagon Success vs Failure in Preventing Hypoglycemia during Closed-loop Treatment of Type 1 Diabetes  
  Castle JR, Engle J, El Youssef J, Massoud R, Ward WK, J Diabetes Sci Technol, 1/1/2010
• Amperometric Glucose Sensors: Sources of Error and Potential Benefit of Redundancy  
  Castle JR, Ward WK, J Diabetes Sci Tech, 1/1/2010
• Modeling Glucagon Action in Patients with Type 1 Diabetes  
  Emami A, El Youssef J, Rabasa-Lhoret R, Pineau J, Castle JR, Haidar A, IEEE Journal of Biomedical and Health Informatics, 1/20/2016
• Join now to see all

Abstracts/Posters

• Comparative PK/PD Study of Liquid Stable G-Pump Glucagon vs. Novo Nordisk Glucagen Delivered to T1DM Patients via an Omnipod Pump
  Castle JR, Advanced Technologies and Treatments for Diabetes, 1/1/2015
• The Use of Redundant Dexcom New Generation Sensors to Assess Sensor Accuracy and Performance
  Castle JR, Diabetes Technology Meeting, 1/1/2012
• Assessment of Hepatic Glycogen Using Magnetic Resonance Spectroscopy: Implications for Bi-hormonal Artificial Pancreas
  Castle JR, American Diabetes Association 72nd Scientific Session, 1/1/2012
• Redundant Sensors Improve the Detection of Hypoglycemia
  Castle JR, Diabetes Technology Meeting, 1/1/2011
• Optimizing the Safety of a Closed-loop System: Use of Rescue Glucagon and Redundant Glucose Sensors
  Castle JR, Diabetes Technology Meeting, 1/1/2009
• Join now to see all

Lectures

• Is Mini-Dose Glucagon the Answer to Preventing Exercise-Related Dysglycemia? 
  Portland, OR - 6/14/2014
• Hypoglycemia 
  1/1/2017
• Glucose Homeostasis 
  OHSU School of Medicine - 1/1/2017
• Diabetes A to Z 
  OHSU Physician Assistant School - 1/1/2017
• Diabetes Review 
  1/1/2017
• Impact of Diabetes 
  Portland, OR - 1/1/2016
• Caring for Patients with Type 1 Diabetes 
  Coos Bay, OR - 1/1/2016
• Injectable Therapies for Type 2 Diabetes and Obesity 
  Portland, OR - 1/1/2016
• Ultra-long Acting Insulin Therapy 
  Anaheim, CA, 2016; San Diego, CA, 2016 - 1/1/2016
• New drugs: Glucagon 
  Bethesda, Maryland - 1/1/2016
• What Do Clinicians Want in an Implantable CGM? 
  Bethesda, Maryland - 1/1/2016
• Cases in Type 1 Diabetes 
  1/1/2015
• Type 2 Diabetes 
  1/1/2015
• Type 1 Diabetes Cases 
  1/1/2015
• General Endocrinology Review 
  1/1/2015
• Advanced Treatment for Type 1 Diabetes 
  1/1/2015
• Combining GLP-1 Receptor Agonists with Basal Insulin: Realizing the Potential in Type 2 Diabetes 
  Santa Clara, CA - 1/1/2015
• Navigating Diabetes Treatment 
  The Portland Clinic - 1/1/2015
• Novel Approach to Reducing Exercise-related Hypoglycemia 
  Paris, France - 1/1/2015
• Clinical Relevance of CGM Accuracy 
  Paris, France - 1/1/2015
• Non-adjunctive Use of Continuous Glucose Monitoring Systems: Future Directions 
  Bethesda, Maryland - 1/1/2015
• Is Mini-Dose Glucagon the Answer to Preventing Exercise-Related Dysglycemia? 
  Portland, OR - 6/15/2014
• Update on Treatment of Type 2 Diabetes 
  1/1/2014
• Diabetes Update 
  1/1/2014
• Diabetic Eye Disease: Bridging the Gap in Patient Care 
  1/1/2014
• Join now to see all

Other

• Monitoring and Preventing Complications 
  Castle JR, HealthSmart Webinar
  1/1/2015